Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
Authors
Keywords
-
Journal
Molecular Cancer
Volume 10, Issue 1, Pages 37
Publisher
Springer Nature
Online
2011-04-14
DOI
10.1186/1476-4598-10-37
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Physical and Functional Interaction of Sequestosome 1 with Keap1 Regulates the Keap1-Nrf2 Cell Defense Pathway
- (2010) Ian M. Copple et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth
- (2010) P. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Advanced pancreatic carcinoma: current treatment and future challenges
- (2010) Anastasios Stathis et al. Nature Reviews Clinical Oncology
- Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials
- (2009) J P Neoptolemos et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
- (2009) S. Homma et al. CLINICAL CANCER RESEARCH
- Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells
- (2009) Hanane Akhdar et al. EUROPEAN JOURNAL OF CANCER
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo
- (2009) Philipp Nuhn et al. Molecular Cancer
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
- (2009) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- RNAi-Mediated Silencing of Nuclear Factor Erythroid-2-Related Factor 2 Gene Expression in Non-Small Cell Lung Cancer Inhibits Tumor Growth and Increases Efficacy of Chemotherapy
- (2008) A. Singh et al. CANCER RESEARCH
- Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer
- (2008) Ghassan El Maalouf et al. CANCER TREATMENT REVIEWS
- Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
- (2008) Tatsuhiro Shibata et al. GASTROENTEROLOGY
- The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system
- (2008) Ian M. Copple et al. HEPATOLOGY
- Multiple Nuclear Localization Signals Function in the Nuclear Import of the Transcription Factor Nrf2
- (2008) Melanie Theodore et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular mechanisms of Nrf2-mediated antioxidant response
- (2008) Wenge Li et al. MOLECULAR CARCINOGENESIS
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
- (2008) T. Shibata et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started